Literature DB >> 19550389

Growth hormone deficiency after traumatic brain injury in adults: when to test and how to treat?

Fahrettin Kelestimur1.   

Abstract

Hypopituitarism has numerous potential causes, and it is becoming clear that traumatic brain injury (TBI), including traffic accidents and sport-related injuries, is commonly associated with pituitary dysfunction. Mechanisms of pituitary damage after TBI include direct injury and vascular problems, and more recent research suggests that autoimmunity may also be involved. There may also be a genetic influence, as the E3 allele of the ApoE gene may provide some protection from post-traumatic hypopituitarism. Studies suggest that patients with mild or moderate TBI are likely to recover pituitary function over time. In patients with severe TBI, however, adrenocorticotrophic hormone and growth hormone deficiencies may persist. Patients who experience TBI should, therefore, be followed up carefully and evaluated for pituitary dysfunction to ensure that appropriate hormone replacement therapy can be provided if needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19550389

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  2 in total

Review 1.  The role of autoimmunity in pituitary dysfunction due to traumatic brain injury.

Authors:  Annamaria De Bellis; Giuseppe Bellastella; Maria Ida Maiorino; Angela Costantino; Paolo Cirillo; Miriam Longo; Vlenia Pernice; Antonio Bellastella; Katherine Esposito
Journal:  Pituitary       Date:  2019-06       Impact factor: 4.107

2.  Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case report.

Authors:  Eric R Braverman; Abdalla Bowirrat; Uma J Damle; Swetha Yeldandi; Thomas Jh Chen; Margaret Madigan; Mallory Kerner; Stanley X Huang; Stella Savarimuthu; Kenneth Blum
Journal:  J Med Case Rep       Date:  2010-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.